Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Babcock & Wilcox Enterprises (BWNB) Research & Development (2016 - 2025)

Babcock & Wilcox Enterprises' Research & Development history spans 12 years, with the latest figure at $941000.0 for Q2 2025.

  • For Q2 2025, Research & Development rose 5.73% year-over-year to $941000.0; the TTM value through Jun 2025 reached $5.0 million, down 25.07%, while the annual FY2024 figure was $5.8 million, 19.53% down from the prior year.
  • Research & Development reached $941000.0 in Q2 2025 per BWNB's latest filing, up from $526000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $4.1 million in Q4 2023 to a low of -$250000.0 in Q4 2022.
  • Average Research & Development over 5 years is $1.1 million, with a median of $924000.0 recorded in 2023.
  • Peak YoY movement for Research & Development: tumbled 56.15% in 2021, then soared 1728.0% in 2023.
  • A 5-year view of Research & Development shows it stood at $609000.0 in 2021, then tumbled by 141.05% to -$250000.0 in 2022, then skyrocketed by 1728.0% to $4.1 million in 2023, then crashed by 48.08% to $2.1 million in 2024, then plummeted by 55.47% to $941000.0 in 2025.
  • Per Business Quant, the three most recent readings for BWNB's Research & Development are $941000.0 (Q2 2025), $526000.0 (Q1 2025), and $2.1 million (Q4 2024).